Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacologic agents for weight reduction.

Christine Haller1, Janice B Schwartz

  • 1Division of Clinical Pharmacology, University of California, San Francisco, USA.

The Journal of Gender-Specific Medicine : JGSM : the Official Journal of the Partnership for Women'S Health at Columbia
|October 17, 2002
PubMed
Summary

Obesity management requires lifestyle changes and sometimes medication. Current weight loss drugs have risks, and unapproved supplements can be dangerous, highlighting the need for safer options.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predictors of Clinical Trial Participation Among Older U.S. Adults With Multimorbidity: A Cross-Sectional Survey.

Clinical and translational science·2026
Same author

Attitudes About Clinical Trials of Medications in Older Hispanic/Latino Adults With Multimorbidity.

Journal of the American Geriatrics Society·2025
Same author

Preferences Regarding Clinical Drug Trial Elements: A Nationally Representative Survey of Older Adults With Multimorbidity.

Journal of the American Geriatrics Society·2025
Same author

Why patients fail to seek information on OTC product interactions with a direct-acting oral anticoagulant: perspectives on information-seeking.

BMC primary care·2025
Same author

"Unjustified Partiality or Impartial Bias? Reckoning with Age and Disability Discrimination in Cancer Clinical Trials".

The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics·2024
Same author

Navigating the Path to Inclusion: Understanding Barriers and Facilitators to Clinical Trial Participation Among Chinese Older Adults in the United States with Multimorbidity.

Journal of general internal medicine·2024

Area of Science:

  • Pharmacology
  • Public Health
  • Obesity Research

Background:

  • Obesity is a significant health concern in the United States adult population.
  • Effective weight loss strategies typically involve a combination of lifestyle changes, dietary adjustments, and physical activity.
  • Pharmacological interventions may supplement these efforts for short-term weight management.

Purpose of the Study:

  • To review the current landscape of weight loss medications and their associated risks.
  • To highlight the potential dangers of over-the-counter products and dietary supplements.
  • To emphasize the ongoing need for safe and effective pharmacologic agents for obesity treatment.

Main Methods:

  • Literature review of existing weight loss medications.
  • Analysis of adverse effects associated with different drug classes.
  • Evaluation of safety concerns regarding non-prescription weight loss products.

Main Results:

  • Adrenergic stimulant medications can cause central nervous system (CNS) and cardiovascular side effects.
  • Antiabsorptive agents may offer a safer profile but are associated with gastrointestinal issues.
  • Over-the-counter products and dietary supplements lack rigorous evaluation and pose risks of life-threatening adverse events.

Conclusions:

  • The development of safe and effective pharmacologic agents for weight loss remains a critical area of research.
  • Careful consideration of risks and benefits is essential when selecting weight loss medications.
  • Increased scrutiny of non-prescription weight loss products is warranted due to potential severe adverse effects.

Related Experiment Videos